Maternal history of recurrent pregnancy loss increases the risk for long-term pediatric respiratory morbidity of the offspring.


Journal

Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590

Informations de publication

Date de publication:
07 2020
Historique:
received: 21 01 2020
accepted: 30 04 2020
pubmed: 20 5 2020
medline: 15 12 2020
entrez: 20 5 2020
Statut: ppublish

Résumé

While the etiology in many cases of recurrent pregnancy loss (RPL) is unclear, recent evidence suggests possible immunological dysfunction, which is also implicated in the pathophysiology of many pediatric respiratory diseases. We sought to investigate whether maternal history of RPL is associated with long-term respiratory morbidity of the offspring. A population based cohort analysis was performed comparing the risk of long-term respiratory morbidity (up to the age of 18 years) of children born to mothers with and without a history of RPL (defined as two or more losses). Respiratory morbidity included hospitalizations involving a predefined set of ICD-9 codes, as recorded in the hospital medical records. Deliveries occurred between the years 1991 and 2014 in a tertiary medical center. A Kaplan-Meier survival curve was constructed to compare cumulative respiratory morbidity, and a Cox proportional hazards model was used to control for confounders. During the study period, 242 187 newborns met the inclusion criteria; 5% (n = 12 182) of which were offspring to mothers with a history of RPL. Respiratory morbidity was significantly more common in the exposed group (6.0% vs 4.8%, P < .001). Specifically, offspring to mothers with a history of RPL had higher rates of obstructive sleep apnea and asthma (P < .05). The Kaplan-Meier survival curve exhibited a higher cumulative incidence of total respiratory morbidity in offspring of mothers with a history of RPL (Log rank P < .001). In the Cox regression, maternal history of RPL was independently associated with increased pediatric respiratory morbidity of the offspring with an adjusted hazard ratio of 1.24 (95 % confidence interval [95%CI], 1.15-1.34, P < .001). Maternal history of RPL is associated with a higher risk of future pediatric respiratory morbidity of the offspring; possibly explained by a common immunological etiology.

Sections du résumé

BACKGROUND
While the etiology in many cases of recurrent pregnancy loss (RPL) is unclear, recent evidence suggests possible immunological dysfunction, which is also implicated in the pathophysiology of many pediatric respiratory diseases.
OBJECTIVE
We sought to investigate whether maternal history of RPL is associated with long-term respiratory morbidity of the offspring.
STUDY DESIGN
A population based cohort analysis was performed comparing the risk of long-term respiratory morbidity (up to the age of 18 years) of children born to mothers with and without a history of RPL (defined as two or more losses). Respiratory morbidity included hospitalizations involving a predefined set of ICD-9 codes, as recorded in the hospital medical records. Deliveries occurred between the years 1991 and 2014 in a tertiary medical center. A Kaplan-Meier survival curve was constructed to compare cumulative respiratory morbidity, and a Cox proportional hazards model was used to control for confounders.
RESULTS
During the study period, 242 187 newborns met the inclusion criteria; 5% (n = 12 182) of which were offspring to mothers with a history of RPL. Respiratory morbidity was significantly more common in the exposed group (6.0% vs 4.8%, P < .001). Specifically, offspring to mothers with a history of RPL had higher rates of obstructive sleep apnea and asthma (P < .05). The Kaplan-Meier survival curve exhibited a higher cumulative incidence of total respiratory morbidity in offspring of mothers with a history of RPL (Log rank P < .001). In the Cox regression, maternal history of RPL was independently associated with increased pediatric respiratory morbidity of the offspring with an adjusted hazard ratio of 1.24 (95 % confidence interval [95%CI], 1.15-1.34, P < .001).
CONCLUSION
Maternal history of RPL is associated with a higher risk of future pediatric respiratory morbidity of the offspring; possibly explained by a common immunological etiology.

Identifiants

pubmed: 32426952
doi: 10.1002/ppul.24813
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1765-1770

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Macklon NS, Geraedts JPM, Fauser BCJM. Conception to ongoing pregnancy: the 'black box' of early pregnancy loss. Hum Reprod Update. 2002;8:333-343.
Stephenson MD. Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril. 1996;66:24-29.
Garrido-Gimenez C, Alijotas-Reig J. Recurrent miscarriage: causes, evaluation and management. Postgrad Med J. 2015;91:151-162.
Kolte AM, van Oppenraaij RH, Quenby S, et al. Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage. Hum Reprod. 2014;29:913-937.
American College of Obstetricians and Gynecologists (ACOG). ACOG practice bulletin. Management of recurrent early pregnancy loss. Number 24, February 2001. Int J Gynaecol Obstet. 2002;78(2):179-190.
van den Boogaard E, Kaandorp SP, Franssen MTM, et al. Consecutive or non-consecutive recurrent miscarriage: is there any difference in carrier status? Hum Reprod. 2010;25(6):1411-1414.
Ford HB, Schust DJ. Recurrent pregnancy loss: etiology, diagnosis, and therapy. Rev Obstet Gynecol. 2009;2(2):76-83.
Acien P, Acien M, Sanchez-Ferrer M. Complex malformations of the female genitourinary tract. New types and revision of classification. Hum Reprod. 2004;19:2377-2384.
Mills JL, Simpson JL, Driscoll SG, et al. Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Eng J Med. 1988;319:1617-1623.
Rai R, Backos M, Rushworth F, Regan L. Polycystic ovaries and miscarriage-a reappraisal. Hum Reprod. 2000;15:612-615.
Anselmo J. Fetal loss associated with excess thyroid hormone exposure. JAMA. 2004;292:691.
Hirahara F, Andoh N, Sawai K, Hirabuki T, Uemura T, Minaguchi H. Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials. Fertil Steril. 1998;70:246-252.
Daya S, Ward S, Burrows E. Progesterone profiles in luteal phase defect cycles and outcome of progesterone treatment in patients with recurrent spontaneous abortion. Am J Obstet Gynecol. 1988;158:225-232.
Sierra S, Stephenson M. Genetics of recurrent pregnancy loss. Semin Reprod Med. 2006;24:17-24.
Goddijn M, Joosten JHK, Knegt AC, et al. Clinical relevance of diagnosing structural chromosome abnormalities in couples with repeated miscarriage. Hum Reprod. 2004;19:1013-1017.
Reindollar RH. Contemporary issues for spontaneous abortion. Does recurrent abortion exist? Obstet Gynecol Clin North Am. 2000;27:541-554.
Hunt JS. Stranger in a strange land. Immunol Rev. 2006;213:36-47.
Kallen CB, Arici A. Immune testing in fertility practice: truth or deception? Curr Opin Obstet Gynecol. 2003;15:225-231.
Fu B, Tian Z, Wei H. TH17 cells in human recurrent pregnancy loss and pre-eclampsia. Cell Mol Immunol. 2014;11:564-570.
Nybo Anderson AM, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ. 2000;320:1708-1712.
Ness RB, Grisso JA, Hirschinger N, et al. Cocaine and tobacco use and the risk of spontaneous abortion. N Eng J Med. 1999;340:333-339.
Sugiura-Ogasawara M. Recurrent pregnancy loss and obesity. Best Pract Res Clin Obstet Gynaecol. 2015;4:489-497.
Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med. 2006;355(21):2226-2235.
Weitzman M, Gortmaker S, Walker DK, Sobol A. Maternal smoking and childhood asthma. Pediatrics. 1990;85:505-11.
Been JV, Lugtenberg MJ, Smets E, et al. Preterm birth and childhood wheezing disorders: a systematic review and meta-analysis. PLoS Med. 2014;11:e1001596.
Rosen CL, Larkin EK, Kirchner HL, et al. Prevalence and risk factors fir sleep-disordered breathing in 8- to 11-year old children: association with race and prematurity. J Pediatr. 2003;142:383-389.
Stokholm J, Sevelsted A, Anderson UD, Bisgaard H. Preeclampsia associates with asthma allergy, and eczema in childhood. Am J Resp Crit Care Med. 2017;195:614-621.
Baumfeld Y, Walfisch A, Wainstock T, et al. Elective cesarean delivery at term and the long-term risk for respiratory morbidity of the offspring. Eur J Pediatr. 2018;177(11):1653-1659.
Sheiner E, Levy A, Katz M, Mazor M. Pregnancy outcome following recurrent spontaneous abortions. Eur J Obstet Gynecol Reprod Biol. 2005;118(1):61-65.
Lichtman Y, Sheiner E, Wainstock T, Segal I, Landau D, Walfisch A. Maternal history of recurrent pregnancy loss is associated of increased risk for long-term pediatric gastrointestinal morbidity in the offspring. Am J Reprod Imunol. 2018;79(2):e12799.
Wang WJ, Hao CF, Yi-Lin Y, et al. Increased prevalence of T helper 17 (Th17) cells in peripheral blood and decidua in unexplained recurrent spontaneous abortion patients. J Reprod Immunol. 2010;84:164-170.
Wang YH, Voo KS, Liu B, et al. A novel subset of CD4(+)T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J Exp Med. 2010;207:2479-2491.
McKinley L, Alcorn JF, Peterson A, et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol. 2008;181(6):4089-4097.
Anderson ME Jr, Buckwald ZS, Ko J, Aurora R, Sandford T. Patients with pediatric obstructive sleep apnea show altered T-cell populations with a dominant TH17 profile. Otolaryngol Head Neck Surg. 2014;150(5):880-886.
Fu B, Li X, Sun R, et al. Natural killer cells promote immune tolerance by regulating inflammatory TH17 cells at the human maternal-fetal interface. Proc Natl Acad Sci USA. 2013;110:E231-E240.
Yokoyama A, Kohno N, Fujino S, et al. Circulating interleukin-6 levels in patients with bronchial asthma. Am J Respir Crit Care Med. 1995;151(5):1354-1358.
Bhattacharjee R, Kim J, Kheirandish-Gozal L, Gozal D. Obesity and obstructive sleep apnea in children: a tale of inflammatory cascades. Pediatr Pulmonol. 2011;46(4):313-323.
Jira M, Antosova E, Vondra V, Strejcek J, Mazakova H, Prazakova J. Natural killer and interleukin-2 induced cytotoxicity in asthmatics, effect of acute antigen-specific challenge. Allergy. 1988;43:294-298.
Lin SJ, Chang LY, Yan DC, Huang YJ, Lin TJ, Lin TY. Decreased intercellular adhesion model-1 (CD54) and L-selectin (CD62L) expression on peripheral blood natural killer cells in asthmatic children with acute exacerbation. Allergy. 2003;58:67-71.
Weinstock TG, Rosen CL, Marcus CL, et al. Predictors of obstructive sleep apnea severity in adenotonsillectomy candidates candidates. Sleep. 2014;37(2):261-269.
Reginald PW, Beard RW, Chapple J, et al. Outcomes of pregnancies progressing beyond 28 weeks gestation in women with a history of recurrent miscarriage. Br J Obstet Gynecol. 1987;94:643-648.
Wong AW, Archer B, Mariee N, Li TC, Laird SM. Do uterine natural killer cell numbers in peri-implantation endometrium predict hypertensive disorder in pregnancy in women with a history of reproductive failure. J Reprod Immunol. 2014;106:34-40.

Auteurs

Sharon Davidesko (S)

Department of Obstetrics and Gynecology, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Tamar Wainstock (T)

The Department of Public Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Eyal Sheiner (E)

Department of Obstetrics and Gynecology, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Daniella Landau (D)

Department of Neonatology, Soroka University Medical Center, Ben Gurion University of the Negev, Beer-Sheva, Israel.

Asnat Walfisch (A)

Department of Obstetrics and Gynecology, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH